Skip to main content
Purple Biotech Ltd. logo

Purple Biotech Ltd. — Investor Relations & Filings

Ticker · PPBT ISIN · IL0007650166 TA Manufacturing
Open in API
Filings indexed 1,071 across all filing types
Latest filing 2025-09-21 Capital/Financing Update
Country IL Israel
Listing TA PPBT

About Purple Biotech Ltd.

https://purple-biotech.com/

Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.

Recent filings

Filing Released Lang Actions
AT THE MARKET OFFERING AGREEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form 6-K filed with the U.S. Securities and Exchange Commission by Purple Biotech Ltd. It details the entry into an 'At The Market' (ATM) offering agreement and the termination of a previous ATM program. This type of filing, which reports on capital-raising activities and financing agreements, falls under the 'Capital/Financing Update' category.
2025-09-21 English
AT THE MARKET OFFERING AGREEMENT
Audit Report / Information Classification · 95% confidence The document is a short regulatory filing from Purple Biotech Ltd submitted via the Israel Securities Authority (MAGNA system). It explicitly states 'Attached hereto is a report on' followed by a reference to an ATM (At-The-Market) agreement and a PDF attachment. Per the 'Menu vs Meal' rule, since this is a short announcement notifying the public of an attached report rather than the full report itself, it is classified as a Report Publication Announcement (RPA). Q3 2025
2025-09-21 English
PROSPECTUS SUPPLEMENT (At-the-Market)
Capital/Financing Update Classification · 98% confidence The document is a prospectus supplement filed with the SEC for an 'at the market' offering of American Depositary Shares (ADSs). It details the terms of the offering, the sales agreement with H.C. Wainwright & Co., and references a Form F-3 registration statement. This type of document is a formal securities offering document, which falls under the 'POS' (Transaction in Own Shares/Capital Change) or 'CAP' (Capital/Financing Update) category. Given the specific nature of an 'at the market' offering and the issuance of new shares/ADSs, 'POS' is the most accurate classification for this type of capital-raising activity.
2025-09-21 English
PROSPECTUS SUPPLEMENT (At-the-Market)
Regulatory Filings Classification · 95% confidence The document is a short regulatory filing from Purple Biotech Ltd via the Israel Securities Authority (MAGNA system). It explicitly states 'Attached hereto is a report on' followed by a reference to a prospectus for an 'At-the-Market' share offering. Since the document is a brief notification announcing the availability of an attached report rather than the full report itself, it falls under the Report Publication Announcement (RPA) category.
2025-09-21 English
CORPORATE PRESETATION- SEPTEMBER 2025
Investor Presentation Classification · 98% confidence The document is a Form 6-K filed with the SEC by Purple Biotech Ltd. It explicitly states that it is attaching an updated company presentation ('Purple Biotech Corporate presentation September 2025') as Exhibit 99.1. While the document contains the presentation slides, the primary purpose of the filing is to formally submit this investor-facing material to the SEC. According to the classification rules, this is an Investor Presentation.
2025-09-16 English
CORPORATE PRESETATION- SEPTEMBER 2025
Audit Report / Information Classification · 95% confidence The document is a short regulatory filing from Purple Biotech Ltd via the Israel Securities Authority (MAGNA system). It explicitly states 'The corporation scheduled the publication of the report' and contains a placeholder indicating an attachment ('Attached hereto is a report on...'). The text mentions that an updated company presentation is attached and available on the website. Per the 'Menu vs Meal' rule, since this is a short announcement regarding the publication of another document (the presentation), it is classified as a Report Publication Announcement (RPA). FY 2025
2025-09-16 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.